Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

Annals of oncology : official journal of the European Society for Medical Oncology·2026

An automated tube-type blood viscometer: validation studies.

Biorheology·2005

Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004

Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy.

Clinical lung cancer·2004

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.

Bone marrow transplantation·2003

Response time of the Opti-Q continuous cardiac output pulmonary artery catheter in the urgent mode to a step change in cardiac output.

Journal of clinical monitoring and computing·2003

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Seminars in oncology·2026

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Seminars in oncology·2026

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Seminars in oncology·2026

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Seminars in oncology·2026

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

Seminars in oncology·2026

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Seminars in oncology·2026

Redox-metabolic cascade NIR-II prodrug for synchronizing compensatory HSPs/P-gp feedback with mitophagy flux impairment against intrinsic thermotolerance.

International journal of pharmaceutics: X·2026

HDAC inhibitors in cancer therapy: sensitization mechanisms, combination strategies, and translational challenges.

Frontiers in cell and developmental biology·2026

Beyond vitamin D: integrating nuclear receptor signaling networks in periodontal health and disease.

Frontiers in physiology·2026

Cellular signaling meets bacterial infection: the integrative role of STAT3.

Frontiers in cellular and infection microbiology·2026

Kidney transplantation in multiple myeloma: patient selection, timing, and post-transplant challenges in the modern therapeutic era.

Clinical kidney journal·2026

A review of advances in research on mechanisms inhibiting kidney stone formation from a network pharmacology perspective.

Frontiers in pharmacology·2026

Related Experiment Videos

Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma

Related Concept Videos

Ovarian reserve as a measure of adjuvant chemotherapy benefit in hormone receptor positive (HR-positive), HER2-negative, node-positive breast cancer in SWOG S1007 (RxPONDER).

An automated tube-type blood viscometer: validation studies.

Docetaxel combined with trastuzumab is an active regimen in HER-2 3+ overexpressing and fluorescent in situ hybridization-positive metastatic breast cancer: a multi-institutional phase II trial.

Preliminary report on reduction of esophagitis by amifostine in patients with non-small-cell lung cancer treated with chemoradiotherapy.

Economic analysis of conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer.

Response time of the Opti-Q continuous cardiac output pulmonary artery catheter in the urgent mode to a step change in cardiac output.

Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy.

Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions.

Bone metastasis in cancer: from microenvironmental remodeling to precision therapy.

Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab.

Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study.

NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor.

Redox-metabolic cascade NIR-II prodrug for synchronizing compensatory HSPs/P-gp feedback with mitophagy flux impairment against intrinsic thermotolerance.

HDAC inhibitors in cancer therapy: sensitization mechanisms, combination strategies, and translational challenges.

Beyond vitamin D: integrating nuclear receptor signaling networks in periodontal health and disease.

Cellular signaling meets bacterial infection: the integrative role of STAT3.

Kidney transplantation in multiple myeloma: patient selection, timing, and post-transplant challenges in the modern therapeutic era.

A review of advances in research on mechanisms inhibiting kidney stone formation from a network pharmacology perspective.

Related Experiment Videos

Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma

Related Concept Videos

Related Articles